Press Release 15 September 2006
Oriola-KD to distribute Meda's pharmaceuticals in Sweden
Oriola-KD Corporation's subsidiary Kronans Droghandel (KD) in Sweden and Meda have made a distribution agreement on Meda's pharmaceuticals, medical products and vaccines in Swedish market. The agreement starts on 1 January 2007 and is valid so far.
Meda's market share in the Swedish pharmaceutical market is 1.2 per cent. KD's market share in the Swedish pharmaceutical distribution market is 43.8 per cent during January-August 2006 (source: IMS Health).
"We have strong trust on KD as a business partner what comes logistics and distribution in the healthcare market," said Anders Lönner, Managing Director of Meda.
"We are pleased that Meda found our logistics offering tempting for their products and we warmly welcome them as a new principal," said Birgitta Gunneflo, Managing Director of KD.
Oriola-KD Corporation is a leading company in pharmaceutical distribution and trade as well as in healthcare and dental trade with business operations in Finland, Sweden, Denmark and Baltic Countries. Invoicing in 2005 was EUR 2.4 billion and the number of personnel is 1.500. Oriola-KD is listed on Helsinki Stock Exchange.
Further information please contact:
Pellervo Hämäläinen Vice President Corporate Communications and IR Tel. +358 10 429 2497 Email: firstname.lastname@example.org
Published by: Oriola-KD Corporation Corporate Communications Harmaaparrankuja 1 FI-02200 Espoo www.oriola-kd.com
Viðskiptablaðið er 25 ára og af því tilefni býðst nýjum áskrifendum að kaupa áskrift á 50% afslætti.
Afmælisverðið er aðeins 2.500 krónur.
Tilboðið er fyrir nýja áskrifendur. Núverandi áskrifendur geta bætt við sig áskrift á þessu verði. Gildir í 4 mánuði. Áskrifendur fá Viðskiptablaðið, Frjálsa verslun og Fiskifréttir sent ásamt vefaðgangi að vb.is og fiskifrettir.is